天然产物研究与开发 ›› 2019, Vol. 31 ›› Issue (增刊1): 152-165.doi: 10.16333/j.1001-6880.2019.S.026

• 综述 • 上一篇    下一篇

柴胡属三萜皂苷成分防治肝病研究进展

罗克,邓玉林,戴荣继*   

  1. 北京理工大学生命学院,北京 100081
  • 出版日期:2019-08-06 发布日期:2019-08-06

Research progress on the mechanism of triterpenoid saponins from radix Bupleuri in treating liver diseases

LUO Ke,DENG Yu-lin,DAI Rong-ji*   

  1. School of Life Science,Beijing Institute of Technology,Beijing 100081,China
  • Online:2019-08-06 Published:2019-08-06

摘要: 三萜皂苷是柴胡中的一类主要的活性成分,其药理学活性一直受到研究学者的重视。迄今为止的研究发现,柴胡皂苷具有类雌激素样作用,能通过减少肝细胞损伤,抑制肝星状细胞激活和增殖进而抑制肝纤维化,以及通过抗炎、抗病毒、抗肿瘤等方式发挥肝病防治作用,且在联合治疗时能增加其他药物的肝脏靶向性和增加肝癌细胞的放射敏感性。本文综述了目前柴胡属三萜皂苷类化学成分及其防治肝病的最新研究进展,旨在为进一步探究其临床应用价值的相关性研究以及肝病新药的设计与开发提供文献依据和研究思路。

关键词: 柴胡属, 三萜皂苷, 肝纤维化, 药理作用

Abstract: Triterpenoid saponins are one of the main active components in radix Bupleuri.Their hepatoprotective effect have gained extensive attention of many researchers.It has been found that saikosaponins have estrogenic-like effects.They can protect the liver by reducing hepatocyte damage,as well as inhibit the activation and proliferation of hepatic stellate cells,and subsequently inhibit hepatic fibrosis.They have potential anti-inflammatory,anti-viral and anti-tumor effects,and they can also increase the liver targeting effect and the radiosensitivity of hepatocarcinoma cells in combination therapy.This article reviews the latest research progress on the hepatoprotective mechanism of saikosaponins,aiming to provide literature basis and research ideas for further exploring the clinical application of saikosaponins and guiding the design and development of new drugs for liver diseases.

Key words: Bupleurum species, triterpenoid saponin, liver fibrosis, pharmacological effect

中图分类号: 

R285